September 11th 2024
EASD 2024: New data shows survodutide may be beneficial for persons with obesity and MASH.
September 10th 2024
Your daily dose of the clinical news you may have missed.
September 6th 2024
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
August 27th 2024
The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.
August 16th 2024
Primary care clinicians can screen at-risk individuals for type 1 diabetes with a single autoantibody panel. It pays to test and educate early, according to this author.
New Diabetes Guidelines Feature Individualized Care
The newly released recommendations outline key goals and the tools to reach them, including a tiered approach to obesity management.
Diabetes News in the New Year
The initial research findings of 2016 include a link between early elevated BMI and later diabetes and heightened dementia risk in women.
New Diabetes Cases Trending Down
Diabetes isn’t going away anytime soon, but a new CDC report reveals encouraging signs of decline.
5 New Things About Diabetes and Risk
Recent research addressed disease risk and how to manage it. Catch up here on the latest headlines.
Testosterone Not Just for Fun Anymore: 3 Questions About Risk
As new teaching replaces old, it seems testosterone replacement may have gone from bad to good and even very good. Here’s how.
10 Juicy Facts About Apples
About that apple-a-day-is there proof it keeps the doctor away? Find out in this slide-show summary of some well-known, and lesser-known, facts about apples and good health.
Primary Care Docs Prefer Tight Glucose Control in T2D
Stringent control was supported even in patients at high risk for related harm. Reasons found for concern over Rx "deintensification" may surprise you.
Antibiotics May Boost Diabetes Risk
A new study also shows that patients with type 2 DM are more prone to infections years before they receive a diagnosis and may end up with an increased demand for antibiotics.
Diabetes Screening Guidelines Said to Fall Short
Recent USPSTF recommendations will go far to identify patients with type 2 diabetes and prediabetes, but maybe not far enough.
7 Developments in Primary Care This Month
Take a quick look at recent primary care happenings that could influence how you practice.
Bisphosphonates Curb Bone Breaks in Women with T2D
Women with type 2 diabetes are at higher risk for fracture at a given bone density than women without the disease, although reasons why are unclear.
4 New Views on Primary Care Practices
Eliminate or keep the annual physical exam, primary care a primary source for children's mental health care, medical screening in dental offices. Here, a summary of the latest concepts in primary care's evolving role.
Hypertension in an African American Man with Diabetes
A 54-year-old African American man with a history of type 2 DM, hypertension, and gout presents for diabetes follow-up. What’s the best therapy for his hypertension?
Sleep Disorders and Glucose Metabolism: What's the Connection?
Common sleep disorders appear to worsen insulin resistance, glucose intolerance, and pancreatic endocrine dysfunction. Here, a closer look at how.
Erectile Dysfunction Doubles Diabetes Risk
ED may raise the risk of diabetes, coffee may lower it, and the evidence against sugary drinks continues to mount.
GLP-1 Agonist Pop Quiz
Take a short break from the clinic and try 2 quick questions about the injectable gut hormone analogs.
3 Weighty Questions About Obesity and Diabetes
Questions you were afraid to ask about weight-loss modalities in the context of obesity and type 2 diabetes are answered here.
Combo Diet-Exercise Programs Trim Diabetes Risk
In the diabetes news: diet and physical activity programs may help prevent type 2 DM, patiromer shows promise for hyperkalemia, metformin may treat portal hypertension.
GLP-1s May Do More Than Just Lower Glucose
A protective endothelial function effect may be seen with exenatide in patients who have long-standing type 2 diabetes in the postprandial period after short-term therapy.
3 Things You (Still) Need to Know About GLP-1 Agonists
Incretin mimetic therapy for type 2 diabetes has been on the market for more than 10 years. Find out what you've learned about the GLP-1 agonists, here.
Targeting Cell Aging May Yield Diabetes Therapy
Heading the diabetes news: therapeutic targeting of cellular senescence, food order affects glucose and insulin levels, sugar causes heart muscle damage, central obesity genetic score linked to type 2 DM risk.
Elevated Triglycerides in a Woman with Type 2 Diabetes
What do current guidelines recommend as first-line treatment for patients like 51-year-old TK? Check out these options.
Diabetes Risk Linked With Hypothyroidism
Hypothyroidism increases the risk of diabetes, but in subclinical hypothyroidism the increased risk is prominent only with statin use.
High Blood Sugar Elevates Breast Cancer Risks
Outcomes are poorer for young women and others with breast cancer when blood sugar levels reflect prediabetes or undiagnosed diabetes. What can you do?
Endocrine Is In: A Top 3 Primary Care Diagnostic Group
Diabetes, obesity, hyperlipidemia, hypothyroidism-these endocrine disorders and others are major reasons why patients come to you. Find out what you know, and don’t know, here.
GLP-1: Used Only as Needed
The ADA recommends GLP-1 agonists as second-line therapy against type 2 diabetes. What makes this class unique in its impact on hyperglycemia?
Metabolic Disease Research Roundup From AACE 2015
Metabolic disorders in patients with diabetes place them at particularly high risk for CV morbidity. Find insights on Dx and Tx in these slides.
Top 10 Reasons Why Patients Come to Primary Care
What brings patients to your office-and not the specialty office down the street? Insights in this slideshow.
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
Metformin Trims Colorectal Cancer Risk in Diabetes
The drug appeared to reduce the risk in the first study to assess its effects on younger patients with diabetes in the United States.